CHLORPHENIRAMINE MALEATE Drug Patent Profile
✉ Email this page to a colleague
When do Chlorpheniramine Maleate patents expire, and what generic alternatives are available?
Chlorpheniramine Maleate is a drug marketed by Aurolife Pharma Llc, Bel Mar, Elkins Sinn, Watson Labs, Pharm Assoc, Avanthi Inc, Anabolic, Bell Pharma, Impax Labs, Ivax Sub Teva Pharms, Kv Pharm, Lederle, Newtron Pharms, Panray, Pharmavite, Pharmeral, Pioneer Pharms, Purepac Pharm, Pvt Form, Roxane, Sun Pharm Industries, Vitarine, and West Ward. and is included in thirty NDAs.
The generic ingredient in CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chlorpheniramine Maleate
A generic version of CHLORPHENIRAMINE MALEATE was approved as chlorpheniramine maleate by AVANTHI INC on May 13th, 2009.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHLORPHENIRAMINE MALEATE?
- What are the global sales for CHLORPHENIRAMINE MALEATE?
- What is Average Wholesale Price for CHLORPHENIRAMINE MALEATE?
Summary for CHLORPHENIRAMINE MALEATE
| US Patents: | 0 |
| Applicants: | 23 |
| NDAs: | 30 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Clinical Trials: | 9 |
| Patent Applications: | 3,641 |
| Drug Prices: | Drug price information for CHLORPHENIRAMINE MALEATE |
| DailyMed Link: | CHLORPHENIRAMINE MALEATE at DailyMed |
See drug prices for CHLORPHENIRAMINE MALEATE
Recent Clinical Trials for CHLORPHENIRAMINE MALEATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Dr. Ferrer BioPharma | Phase 2/Phase 3 |
| Hospital CEMESA Cortés, San Pedro Sula, Honduras | Phase 2/Phase 3 |
| Marcos Sanchez-Gonzalez, MD, PhD | Phase 2/Phase 3 |
Pharmacology for CHLORPHENIRAMINE MALEATE
| Drug Class | Histamine-1 Receptor Antagonist |
| Mechanism of Action | Histamine H1 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for CHLORPHENIRAMINE MALEATE
Anatomical Therapeutic Chemical (ATC) Classes for CHLORPHENIRAMINE MALEATE
US Patents and Regulatory Information for CHLORPHENIRAMINE MALEATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | CHLORPHENIRAMINE MALEATE | chlorpheniramine maleate | TABLET;ORAL | 080791-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | CHLORPHENIRAMINE MALEATE | chlorpheniramine maleate | TABLET;ORAL | 085139-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aurolife Pharma Llc | CHLORPHENIRAMINE MALEATE | chlorpheniramine maleate | CAPSULE, EXTENDED RELEASE;ORAL | 070797-001 | Aug 12, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Panray | CHLORPHENIRAMINE MALEATE | chlorpheniramine maleate | TABLET;ORAL | 083243-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roxane | CHLORPHENIRAMINE MALEATE | chlorpheniramine maleate | TABLET;ORAL | 080626-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
